Search

The article discusses the National Institutes of Health (NIH) which has faced a threatened 22% reduction in its funding and steps were taken to shore up the overall NIH funding. It states that the NIH supports the extramural research by capping grant funding for indirect costs called facilities and administrative costs. It also states that longtime supporters of biomedical research in the House and Senate have acted quickly to try to block the proposed cap.

The article discusses U.S. federal support for scientific community's research and development projects. Explored is the impact of government funding on scientific advancements as well as on productivity ratios of science projects. Also tackled are budget proposals for various government agencies in the country.

The article offers insight on the roadmap for nuclear energy innovation in the U.S. in terms of support for the existing nuclear fleet, efforts for emission reduction and further carbon dioxide mitigation. Topics discussed include the Nuclear Regulatory Commission reform, uncertain nuclear energy innovation outlook, and the funding for nuclear energy research and development.

The article discusses the U.S. public funding of biomedical science which is by direct path through the National Institute of Health's intramural research efforts and extramural support of university research and the indirect path through the purchases of pharmaceutical products and services by Medicare and Medicaid, Veterans Administration and Affordable Care Act. It states that part of the revenue comes from sales and are invested in industrial pharmaceutical research and development.

The article offers news briefs related to science and technology developments in the U.S. including the research and development (R&D) funding for fiscal year (FY) 2013, hearings which examined R&D activities at the Environmental Protection Agency (EPA), and hearings on the U.S. planetary science, adapted from the newsletter "Science and Technology in Congress."

The article reports on the science and technology-related issues, polices and regulations in 2011 in the U.S. In a bill signed by President Barack Obama, there are reductions in budgets of several research and development (R&D) programs including defense, nondefense, and energy. A federal funding of human embryonic stem cell research is approved by the U.S. Appeals Court for the D.C. Circuit. A Senate hearing scrutinizes the Food and Drug Administration's (FDA) medical device approval process.

The article focuses on the association between science and democracy in the U.S. Topics discussed include the expansion of technical and scientific class, the engagement of the public in science, the funding for research and development, the significant role played by scientific advisers, and the issue of democracy and science relations with the possible election of presidential candidate Donald Trump.

The article discusses the proposed budget for the Federal research and development by the U.S. president Barack Obama for the fiscal year 2017. It mentions that in 2017 the Federal budget deficit is expected to grow and will add additional downward pressure. In addition to this, the long-term projections from the Congressional Budget Office (CBO) states that in 2016 the deficit will rise by 105 billion dollars.

The article presents a discussion of the implications of the U.S. government's proposed Fiscal Year 2015 budget to the research and development (R&D) field, adapted from the newsletter "Science and Technology in Congress" by the Office of Government Relations of the American Association for the Advancement of Science. It is inferred that the budget has been managed to select programs such as renewable energy and energy efficiency. Concerns related to R&D spending are explored.

The article discusses U.S. President Donald Trump's insufficient budget allocation for the science sector for fiscal year 2018. Tackled are budget proposals for government agencies which include National Institutes of Health (NIH), Department of Energy (DOE), National Aeronautics and Space Administration (NASA) and National Institute of Standards and Technology. Also explored is the reduction of government's financial support for Department of Agriculture research and development programs.

The article presents a discussion of science practices in the U.S., adapted from the e-newsletter "Policy Alert." Topics discussed include the research and development (R&D) budget for the science and technology projects, the implementation of energy bill and the modernization of the U.S. regulatory system for biotechnology products.

The article presents a discussion on the bills signed by U.S. President Barack Obama on November 18, 2011 with regards to the funding for the research and development (R&D) accounts in various agencies for the fiscal year (FY) 2012, adapted from the newsletter "Science and Technology in Congress."

The article discusses the impact of the sequestration in the operations of research agencies in the U.S. It says that the budget cuts on nondefense and defense research and development (R&D) will be $9.0 billion in the fiscal year 2013. According to the National Institutes of Health (NIH), the impacts can include the unissuance of continuation awards and reduced grants. The Continuing Appropriations Act which limits political science research funds is also cited.